This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Short, K. R. Articles by Nair, K. S. Search for Related Content PubMed PubMed Citation Articles by Short, K. R. Articles by Nair, K. S. Related Collections Neuroendocrinology and Pituitary Metabolism

Enhancement of Muscle Mitochondrial Function by Growth Hormone

Endocrinology Research Unit, Mayo Clinic School of Medicine, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: K. S. Nair, M.D., Ph.D., Mayo Clinic School of Medicine, Endocrinology Research Unit, 5-194 Joseph, 200 First Street SW, Rochester, Minnesota 55905. E-mail: nair.sree{at}mayo.edu.

Context: Although GH promotes growth and protein anabolism, which are ATP-dependent processes, the GH effect on mitochondrial regulation remains to be determined.

Objective: Our objective was to determine the acute effect of GH on mitochondrial oxidative capacity in skeletal muscle of healthy subjects.

Design and Setting: The study was a randomized crossover design at an academic medical center.

Participants: Nine healthy men and women completed the study.

Intervention: GH (150 µg/h) or saline was infused for 14 h on separate days, and muscle biopsies were obtained.

Main Outcome Measures: Outcome measures included mitochondrial function, gene expression, and protein metabolism.

Results: The 4-fold increase in plasma GH caused elevations in plasma IGF-I, insulin, glucose, and free fatty acids and a shift in fuel selection, with less carbohydrate (–69%) and leucine (–43%) oxidation and 29% more fat oxidation. Muscle mitochondrial ATP production rate and citrate synthase activity were increased 16–35% in response to GH. GH also resulted in higher abundance of muscle mRNAs encoding IGF-I, mitochondrial proteins from the nuclear (cytochrome c oxidase subunit 4) and mitochondrial (cytochrome c oxidase subunit 3) genomes, the nuclear-derived mitochondrial transcription factor A, and glucose transporter 4. Although GH increased whole-body protein synthesis (nonoxidative disposal of leucine), no effect on synthesis rate of muscle mitochondrial proteins was observed.

Conclusions: These results demonstrate that acute GH action promotes an increase in mitochondrial oxidative capacity and abundance of several mitochondrial genes. These events may occur through direct or indirect effects of GH on intracellular signaling pathways but do not appear to involve a change in mitochondrial protein synthesis rate.

This article has been cited by other articles:

				N. Moller, L. C. Gormsen, O. Schmitz, S. Lund, J. O. L. Jorgensen, and N. Jessen Free Fatty Acids Inhibit Growth Hormone/Signal Transducer and Activator of Transcription-5 Signaling in Human Muscle: A Potential Feedback Mechanism J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2204 - 2207. [Abstract] [Full Text] [PDF]

				N. Moller and J. O. L. Jorgensen Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects Endocr. Rev., April 1, 2009; 30(2): 152 - 177. [Abstract] [Full Text] [PDF]